Inactive Instrument

Albany Molecular Research, Inc. Share Price

Equities

Duration

Period

Style

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17/18/17	PU
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	05/18/05	PU
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19/17/19	PU
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30/17/30	PU
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09/17/09	PU

Albany Molecular Research, Inc. : AMRI annonce un accord de collaboration avec Lilly pour des services internalisés dans le domaine de la chimie	08/11/08
ALBANY MOLE RES : AMRI fait l'acquisition d'Excelsyn Ltd.	18/10/18
ALBANY MOLECULAR R COM USD0.01 : AMRI ouvre un nouveau centre de recherche à Budapest en Hongrie	22/09/22
Albany Molecular Res : AMRI a nommé un nouveau directeur pour son secteur chimie de son site européen	28/07/28
Albany Molecular Res : ComGenex est rebaptisé AMRI Hungary ; une gamme complète de services AMRI est désormais disponible pour les clients de ComGenex	26/06/26

Managers	Title	Age	Since
Philip W Macnabb CEO	Chief Executive Officer	-	01/23/01
Meera Khullar CMP	Compliance Officer	-	01/19/01
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01/18/01

Members of the board	Title	Age	Since
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B